Clinical Trial Update: Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial of durvalumab with chemotherapy followed by surgery or chemoradiation and continued durvalumab in borderline resectable stage III non-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• Durvalumab (durvalumab)

Snippet

Sponsor: Bi Nan | Conditions: Non-small Cell Lung Cancer Stage III, Borderline Resectable Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING